Statement by the Board of Directors of Swedish Orphan Biovitrum AB in relation to the public cash offer by Advent and GIC
The Board of Directors of Swedish Orphan Biovitrum AB unanimously recommends that the shareholders of Swedish Orphan Biovitrum AB accept the offer Background This statement is made by the Board of Directors (the “Board”) of Swedish Orphan Biovitrum AB (publ) (“Sobi” or the “Company”) pursuant to Section II.19 of Nasdaq Stockholm’s Takeover Rules (the “Takeover Rules”). Advent International Corporation[[[1]]] (“Advent”) and Aurora Investment Pte Ltd ("Aurora")[[[2]]], an affiliate of GIC Pte Ltd (“GIC”), through Agnafit Bidco AB (“Agnafit Bidco”), have today announced a public cash